Future Oncology is a premier peer-reviewed journal published by FUTURE MEDICINE LTD, dedicated to advancing research and innovation within the field of oncology. Established in 2005 and set to continue through 2024, this journal serves as an essential resource for researchers, healthcare professionals, and students engaged in cancer studies. With its emphasis on groundbreaking findings and multidisciplinary approaches, Future Oncology holds an esteemed reputation, reflected in its 2023 category quartiles ranking it in Q2 for Cancer Research and Q1 for Medicine (miscellaneous). The journal is indexed in Scopus, showcasing its rigorous content, with rankings in the 63rd percentile for Oncology and the 46th percentile for Cancer Research. Although it does not operate on an open-access model, its commitment to disseminating cutting-edge findings makes it an invaluable asset for those seeking to stay at the forefront of oncology research.Future Oncology strives to bridge the gap between laboratory and clinical research, fostering collaboration and appreciation for the complexities of cancer treatment.

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

INTERNAL MEDICINE JOURNAL, published by Wiley, stands as a prominent platform in the field of internal medicine, reflecting the latest advancements and research across a broad spectrum of topics within the discipline. With an ISSN of 1444-0903 and an E-ISSN of 1445-5994, this journal caters to a global audience, primarily situated in the United Kingdom. As a testament to its scholarly impact, the journal holds a Q2 ranking in the Internal Medicine category for 2023, indicating its influence within the field, and ranks #82 out of 167 in Scopus, placing it within the 51st percentile. Covering a convergence of years from 2001 to 2024, the INTERNAL MEDICINE JOURNAL aims to disseminate high-quality research that advances clinical practice, with diverse open access options available for broader readership and engagement. This publication is essential for researchers, healthcare professionals, and students seeking to deepen their understanding of internal medicine and contribute to its ongoing evolution.

Onkologie is a peer-reviewed academic journal published by SPRINGER HEIDELBERG, focusing on the evolving fields of Oncology and Hematology. Established as a significant platform for the dissemination of research in these crucial areas of medicine, Onkologie aims to provide insights into the latest advancements, therapeutic strategies, and clinical practices that shape patient care in oncology and hematology. Despite its current placement in the Q4 category for both disciplines, this journal aspires to foster scholarly dialogues and enhance its contributions to the scientific community. The journal is based in Germany and encourages submissions that promote a deeper understanding of oncology's complex landscape, ensuring that researchers, clinicians, and students have access to a wealth of knowledge essential for clinical practice and further research. With an ISSN of 2731-7226 and E-ISSN of 2731-7234, Onkologie is committed to maintain high standards in publication and peer review, driving innovation and discovery in the fields it represents.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

Clinical and Investigative Medicine is a prestigious journal dedicated to advancing the fields of clinical research and medical practice, published by the Canadian Society for Clinical Investigation. With a history of insightful contributions since its inception in 1978, the journal serves as a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and explore critical issues facing contemporary medicine. Housed within the Q3 quartile of the Medicine category, it boasts an impressive Scopus ranking of #280/636, placing it within the 56th percentile amongst its peers. Although it operates on a subscription basis, the journal remains accessible to a broad audience interested in comprehensive reviews, original research, and cutting-edge methodology, ensuring that vital information reaches a global readership. Submit your research to Clinical and Investigative Medicine and contribute to the ongoing dialogue that shapes the future of patient care and medical innovation.

JBJS Reviews is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the fields of Orthopedics, Sports Medicine, and Surgery. With an impactful presence in the medical community, the journal is recognized for its high-quality and peer-reviewed content that boasts an impressive ranking, including a Q1 quartile status in both Orthopedics and Surgery as of 2023. This esteemed publication is indexed in Scopus, achieving a rank of #115 out of 551 in Medicine Surgery and #88 out of 321 in Medicine Orthopedics and Sports Medicine. Since its inception in 2014, JBJS Reviews has served as a critical platform for advancing knowledge and fostering innovation, offering researchers, professionals, and students valuable insights into the latest advancements, evidence-based practices, and trends in the orthopedic field. Although not currently offering open access, JBJS Reviews remains a pivotal resource for those aiming to stay at the forefront of orthopedic and surgical excellence.

Chiropractic & Manual Therapies is a premier open-access journal published by BMC, dedicated to advancing the fields of Chiropractic, Complementary and Alternative Medicine, and Physical Therapy. Since its inception in 2011, the journal has established its reputation within the academic community, evidenced by its Q1 ranking in Chiropractics and Complementary and Alternative Medicine, and Q2 in Physical Therapy, Sports Therapy, and Rehabilitation as of 2023. With an impressive Scopus ranking placing it in the top 5% for Chiropractics and maintaining a strong presence in the complementary medicine sector, Chiropractic & Manual Therapies serves as a critical platform for researchers, practitioners, and students seeking to disseminate innovative findings and practical advancements in manual therapies. Located in the United Kingdom, the journal not only promotes accessible research but also contributes to the ongoing discourse in healthcare practices, ensuring valuable insights are shared widely among professionals and the academic community.